Treatment of Juvenile Myoclonic Epilepsy with Myoclonic Seizures in Adults 16 and Older

Juvenile myoclonic epilepsy (JME) presenting with myoclonic seizures in adults aged 16 years and older requires structured antiepileptic management calibrated to this age group and seizure type.

Management for this population involves combination antiepileptic therapy — the specific agents, their selection criteria, and the full regimen are defined in the complete protocol.